These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9491023)

  • 21. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States).
    Norman SA; Localio AR; Zhou L; Weber AL; Coates RJ; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Lee NC; Nadel MR
    Cancer Causes Control; 2006 Sep; 17(7):921-9. PubMed ID: 16841259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of three decades of screening mammography on breast-cancer incidence.
    Bleyer A; Welch HG
    N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of mammography services by women aged > or = 65 years enrolled in Medicare--United States, 1991-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):777-81. PubMed ID: 7565562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening practices among women in the United States, 2000.
    Coughlin SS; Uhler RJ; Bobo JK; Caplan L
    Cancer Causes Control; 2004 Mar; 15(2):159-70. PubMed ID: 15017128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries.
    Fisher KJ; Lee JH; Ferrante JM; McCarthy EP; Gonzalez EC; Chen R; Love-Jackson K; Roetzheim RG
    Cancer; 2013 Aug; 119(16):2964-72. PubMed ID: 23677482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammography underutilization among older women in Connecticut.
    Preston JA; Scinto JD; Ni W; Wang Y; Galusha D; Schulz AF; Petrillo MK
    J Am Geriatr Soc; 1997 Nov; 45(11):1310-4. PubMed ID: 9361655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic association between mammography use and mortality reduction in the US.
    Das B; Feuer EJ; Mariotto A
    Cancer Causes Control; 2005 Aug; 16(6):691-9. PubMed ID: 16049808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess mortality from breast cancer in relation to mammography screening in northern Sweden.
    Lenner P; Jonsson H
    J Med Screen; 1997; 4(1):6-9. PubMed ID: 9200054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates.
    Miller JW; King JB; Ryerson AB; Eheman CR; White MC
    AJR Am J Roentgenol; 2009 Feb; 192(2):352-60. PubMed ID: 19155394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in breast cancer screening among women from 65 to 74 years of age: trends from 1987-1993 and barriers to screening.
    Coleman EA; O'Sullivan P
    J Women Aging; 2001; 13(3):23-39. PubMed ID: 11722004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. County-Level Factors Predicting Low Uptake of Screening Mammography.
    Heller SL; Rosenkrantz AB; Gao Y; Moy L
    AJR Am J Roentgenol; 2018 Sep; 211(3):624-629. PubMed ID: 30016143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why is breast-cancer mortality declining?
    Jatoi I; Miller AB
    Lancet Oncol; 2003 Apr; 4(4):251-4. PubMed ID: 12681269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
    van Ravesteyn NT; Schechter CB; Near AM; Heijnsdijk EA; Stoto MA; Draisma G; de Koning HJ; Mandelblatt JS
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):112-22. PubMed ID: 21119071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast cancer].
    Fukuda M; Miyamoto K; Hashizume R; Okamoto J; Kawamoto H; Yabuki Y; Ogata H; Ohta T
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1900-6. PubMed ID: 12465388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
    Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
    Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.